Stimulation of epidermal hyperplasia and tumorigenesis by resident p16INK4a-expressing cells
Open Access
- 25 September 2020
- journal article
- editorial
- Published by Taylor & Francis in Molecular & Cellular Oncology
- Vol. 7 (6)
Abstract
P16INK4a (CDKN2A) is a central tumor-suppressor and activator of senescence. We recently found that prolonged expression of p16INK4a in epidermal cells induces hyperplasia and dysplasia through Wnt-mediated stimulation of neighboring keratinocytes. The study suggests a pro-tumorigenic function of p16INK4a in early epidermal lesions, which could potentially be targeted by senolytic therapy.Keywords
Funding Information
- Israel Science Foundation (1009/13, 2092/18)
- DKFZ-MOST ((CA-161) (I.B.))
- Israel Council for Higher Education (N.A.)
This publication has 10 references indexed in Scilit:
- Senescent cell turnover slows with age providing an explanation for the Gompertz lawNature Communications, 2019
- Unmasking senescence: context-dependent effects of SASP in cancerNature Reviews Cancer, 2019
- Senolytic therapies for healthy longevityScience, 2019
- Senescence in Health and DiseaseCell, 2017
- Experimental Evolution to Study Virus EmergenceCell, 2017
- Directed elimination of senescent cells by inhibition of BCL-W and BCL-XLNature Communications, 2016
- Naturally occurring p16Ink4a-positive cells shorten healthy lifespanNature, 2016
- p16INK4a reporter mice reveal age-promoting effects of environmental toxicantsJournal of Clinical Investigation, 2013
- Tumor Suppressor and Aging Biomarker p16INK4a Induces Cellular Senescence without the Associated Inflammatory Secretory PhenotypeJournal of Biological Chemistry, 2011
- Ink4a/Arf expression is a biomarker of agingJournal of Clinical Investigation, 2004